Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > US economic recovery
View:
Post by Kingpin68 on Dec 07, 2020 11:56am

US economic recovery

So, does anyone know what this really means, launching US sites pending economic recovery. Is it job numbers, stock market, Covid cases. What's the criteria ? Seems vague. Why should any of that stop US sites if the hospitals have capacity to do it.
Comment by Eoganacht on Dec 07, 2020 12:41pm
In my opinion it's cheerful gobbledegook. The pandemic is currently at it's height. When will the United States economy recover from the COVID-19 pandemic? Certainly not in 1Q21. Maybe 2Q21 or 3Q21? Theralase keep talking about launching US sites in 4Q20 and 1Q21, subject to impossible conditions.
Comment by ScienceFirst on Dec 07, 2020 12:54pm
Surgeries, oncology treatments, etc ... are all postponed by COVID-19 patient cases.  Hospital budgets are strained.  All confirmed by the US Surgeon General. This surge is different because "it’s really about health care capacity," Surgeon General says Dr. Jerome Adams detailed how health care capacity is the biggest problem caused by the current spike
Comment by tamarindo1 on Dec 07, 2020 3:27pm
USA Today/Suffolk Poll. Sept. 2/3 polled won't take the vaccine. CNN Poll. only 1/2 Americans willing to take vaccine. STAT-Harris Poll. Nov 10. Most citizens won't take vaccine unless it cuts risk in half. Biden Dec 4. Vaccine will not be mandatory. IMO it would be best for TLT( for at least the next 6 mos) to concentrate their best efforts in Canada, at least here we have a head ...more  
Comment by ScienceFirst on Dec 07, 2020 4:18pm
Eoganacht is right. 6 days ago ...  COVID-19: Elective surgeries back on hold around US  With hospitals increasingly full, Americans can’t get important medical treatments The term "elective surgery" covers a wide range of hospitalizations, many of which are serious, such as removing a cancerous tumor. And this below, was on Nov. 19.  Just imagine now, as COVID-19 ...more  
Comment by enriquesuave on Dec 07, 2020 4:45pm
The vaccines should do the job.  As soon as hospitalizations drop even slightly, we should see trial sites moving forward and fast hopefully.  Next week in the US and End of December-January in Canada.  IMO 
Comment by ScienceFirst on Dec 07, 2020 5:04pm
Canada is receiving its first doses next week.  259,000 out of 29 millions they ordered. Same ratio for the US. 20M out of the 1.01 billion doses ordered.  Operation Warp Speed plans to vaccinate 20 million people this month. Not enough to vaccine everybody.  And 2 doses are required, spaced by 30 days, if I'm not mistaken for the Pfizer/BioNTech one. And it will all go the ...more  
Comment by Eoganacht on Dec 07, 2020 9:00pm
I very much hope you're right.
Comment by CancerSlayer on Dec 07, 2020 10:48pm
  Agree.  The U.S. is rapidly ramping up vaccine inventory for its healthcare workers.  Most heavily impacted states should start vaccinating before month end (post anticipated approval within the next 2 weeks).  Between Moderna & Pfizer, there should roughly be 25 to 30 million doses available in the US by year end.  So even for a two-dose vaccine (booster is given ...more  
Comment by tdon1229 on Dec 08, 2020 2:35am
Comment by Pandora on Dec 08, 2020 10:32am
I still think they are lacking a good approved dependable therapeutic for all those hospitalizations that are occurring by the thousands. An excerpt: "The first two are the Pfizer and Moderna vaccines while the third expected EUA is from CytoDyn Inc. (OTCMKTS: CYDY).  This is a repurposed monoclonal antibody that is the only remaining phase 3 drug candidate with a mortality benefit that ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250